NCT06755710 (PEP) is a NA clinical trial of Introductory PTSD module in PTSD, sponsored by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital.

Who is sponsoring NCT06755710?

NCT06755710 is sponsored by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital.

What drugs are being tested in NCT06755710?

Interventions in NCT06755710: Introductory PTSD module, Shared Decision Making, Treatment as Usual, Standardised treatments.

What condition does NCT06755710 study?

NCT06755710 studies PTSD, Depression Disorders, Patient Engagement.

Is NCT06755710 still recruiting?

NCT06755710 is currently recruiting now. Last updated 9 April 2025.

Last reviewed 2025-04-09 · How we verify

NCT06755710: PEP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patient Engagement in PTSD Treatment (PEP)

Recruiting now NA Last updated 9 April 2025

What this trial tests

NA trial testing Introductory PTSD module in PTSD in 427 participants. Currently enrolling.

Timeline

2 January 2025

Primary endpoint
29 February 2028

31 August 2028

Quick facts

Lead sponsor	Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	427
Start date	2 January 2025
Primary completion	29 February 2028
Estimated completion	31 August 2028
Sites	1 location across Denmark

Drugs / interventions tested

Introductory PTSD module
Shared Decision Making
Treatment as Usual
Standardised treatments

Conditions studied

PTSD — all drugs for PTSD →
Depression Disorders — all drugs for Depression Disorders →
Patient Engagement — all drugs for Patient Engagement →

Sponsor

Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital

Who can join

18 and older, any sex, with PTSD or Depression Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical study is to improve the outcome of outpatient PTSD treatment at two clinics treating majority ethnic Danes and refugees with PTSD respectively. The study will consist of two similar randomized controlled trials. The main questions the study aims to answer are: * Does an added motivation enhancement module as a precursor for PTSD treatment reduce dropout and increase treatment outcome? * Does an added Shared Decision-Making session which facilitate individualized treatment yield a superior outcome compared to PTSD treatment and PTSD treatment supplemented by motivation enhancement? Participants are recruited at two different clinics, Psychotherapeutic Unit (PU) and Competence Centre for Transcultural Psychiatry (CTP). At PU the participants are randomized to one of two arms, and at CTP to one of three arms. One arm is the control group where participants will receive treatment as usual (TAU), one arm is the first intervention group where the participants will receive an Introductory PTSD module consisting of four sessions focusing on enhancing motivation for PTSD treatment, before continuing in TAU. The last arm is the second intervention group, which will only take place at CTP. Here the patient will receive the Introductory PTSD module followed by a session of Shared Decision Making, where the participant together with the MD decides which of four standardized treatment courses they will receive. The treatment for all patients will last between 8-13 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for PTSD

Currently open trials in the same condition.

NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
NCT07010757 — Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial · NA · recruiting
NCT07372586 — Behavioral Health Collaborative Care Model in an ICU Recovery Clinic · NA · recruiting
NCT07390786 — Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot · NA · recruiting
NCT07469098 — Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events · Phase 2 · recruiting

Other Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital trials

Trials by the same sponsor.

NCT07404085 — Epigenetic Enhancement of Cognitive Training in Aging Mood Disorder Populations · NA · recruiting
NCT07302165 — PreParent: Internet-based Digital Tools to Screen for and Prevent Postpartum Depression in Parents-to-be · NA · enrolling by invitation
NCT06919133 — The Effect of Digital Markers in the Self-management of Depressive Symptoms · NA · enrolling by invitation
NCT06993831 — ENGAGE: Virtual Reality-based Psychotherapy for Negative Symptoms in Schizophrenia · NA · completed
NCT06563466 — PEGASUS - Improving Treatment for Patients with Emotionally Unstable Personality Disorder · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06755710 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Last refreshed: 9 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06755710.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing